Vanda Pharmaceuticals
VNDA • NASDAQ • Stock Fundamentals
Vanda Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Mihael H. Polymeropoulos, with a market cap of $366.8M.
Market Cap$366.8M
Employees203.0
CEOMihael H. Polymeropoulos
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026
View reportNext EarningsJul 30, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Vanda Pharmaceuticals FAQ
Common questions about Vanda Pharmaceuticals
Vanda Pharmaceuticals (VNDA) has a market capitalization of $366.8M and trades on NASDAQ.
Vanda Pharmaceuticals has approximately 203 employees.